[HTML][HTML] Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection
…, S Rusconi, A Riva, D Corradi, P Santus… - Nature …, 2021 - nature.com
Patients with coronavirus disease 2019 (COVID-19) are reported to have a greater prevalence
of hyperglycaemia. Cytokine release as a consequence of severe acute respiratory …
of hyperglycaemia. Cytokine release as a consequence of severe acute respiratory …
[HTML][HTML] Anxiety and depression in COPD patients: the roles of gender and disease severity
…, M Verga, M Reggente, FM Casanova, P Santus… - Respiratory …, 2006 - Elsevier
BACKGROUND: The aim of our study was to assess the prevalence of anxiety and depression
in the whole chronic obstructive pulmonary disease (COPD) population and in subgroups …
in the whole chronic obstructive pulmonary disease (COPD) population and in subgroups …
Joint statement on the role of respiratory rehabilitation in the COVID-19 crisis: the Italian position paper
…, F Gigliotti, G Castellana, P Banfi, E Guffanti, P Santus… - Respiration, 2020 - karger.com
Due to the exponential growth of the number of subjects affected by coronavirus disease
2019 (COVID-19), the entire Italian health care system had to respond promptly and in a very …
2019 (COVID-19), the entire Italian health care system had to respond promptly and in a very …
Helmet CPAP treatment in patients with COVID-19 pneumonia: a multicentre cohort study
…, L Perotto, V Monzani, P Santus… - European …, 2020 - Eur Respiratory Soc
Patients with coronavirus disease 2019 (COVID-19) pneumonia can develop hypoxaemic
acute respiratory failure (hARF) with the need for positive end-expiratory pressure (PEEP). …
acute respiratory failure (hARF) with the need for positive end-expiratory pressure (PEEP). …
[HTML][HTML] Close correlation between anxiety, depression, and asthma control
F Di Marco, M Verga, P Santus, F Giovannelli… - Respiratory …, 2010 - Elsevier
BACKGROUND: We investigated the correlation between patients’ characteristics, including
anxiety and depression, and the level of asthma control evaluated by asthma control test (…
anxiety and depression, and the level of asthma control evaluated by asthma control test (…
Prolonged low-dose methylprednisolone in patients with severe COVID-19 pneumonia
…, P Confalonieri, GU Meduri, P Santus… - Open forum …, 2020 - academic.oup.com
Background In hospitalized patients with coronavirus disease 2019 (COVID-19) pneumonia,
progression to acute respiratory failure requiring invasive mechanical ventilation (MV) is …
progression to acute respiratory failure requiring invasive mechanical ventilation (MV) is …
Understanding the burden of pneumococcal disease in adults
F Blasi, M Mantero, PA Santus… - Clinical Microbiology and …, 2012 - Wiley Online Library
Clin Microbiol Infect 2012; 18 (Suppl. 5): 7–14 Abstract Streptococcus pneumoniae causes
different types of acute, invasive and non‐invasive clinical infections, being the most …
different types of acute, invasive and non‐invasive clinical infections, being the most …
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma …
…, A Papi, G Pelaia, L Pini, P Santus… - The lancet respiratory …, 2021 - thelancet.com
Background ANDHI was done to assess the efficacy of benralizumab, including onset of effect
and impact on health-related quality of life (HRQOL), exacerbation rate, lung function, and …
and impact on health-related quality of life (HRQOL), exacerbation rate, lung function, and …
Oxidative stress and respiratory system: pharmacological and clinical reappraisal of N-acetylcysteine
P Santus, A Corsico, P Solidoro, F Braido… - COPD: Journal of …, 2014 - Taylor & Francis
The large surface area for gas exchange makes the respiratory system particularly susceptible
to oxidative stress-mediated injury. Both endogenous and exogenous pro-oxidants (eg …
to oxidative stress-mediated injury. Both endogenous and exogenous pro-oxidants (eg …
Enhanced platelet inhibition treatment improves hypoxemia in patients with severe Covid-19 and hypercoagulability. A case control, proof of concept study
…, D Radovanovic, GB Forleo, P Santus - Pharmacological research, 2020 - Elsevier
Patients affected by severe coronavirus induced disease-2019 (Covid-19) often experience
hypoxemia due to alveolar involvement and endothelial dysfunction, which leads to the …
hypoxemia due to alveolar involvement and endothelial dysfunction, which leads to the …
